US Stock MarketDetailed Quotes

RCEL Avita Medical

Watchlist
  • 8.220
  • -0.310-3.63%
Close May 23 16:00 ET
  • 8.220
  • 0.0000.00%
Post 16:07 ET
212.07MMarket Cap-4670P/E (TTM)

Avita Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
5.25%11.1M
45.68%50.14M
50.13%14.2M
50.08%13.65M
41.01%11.75M
39.94%10.55M
146.64%34.42M
36.32%9.46M
3.73%9.09M
8.34M
Operating revenue
5.25%11.1M
45.68%50.14M
50.13%14.2M
50.08%13.65M
41.01%11.75M
39.94%10.55M
146.64%34.42M
36.32%9.46M
3.73%9.09M
--8.34M
Cost of revenue
-9.24%1.51M
28.79%7.78M
33.33%1.8M
38.10%2.11M
59.02%2.2M
-6.24%1.67M
217.11%6.04M
64.87%1.35M
-28.70%1.53M
1.39M
Gross profit
7.97%9.59M
49.27%42.36M
52.92%12.4M
52.50%11.53M
37.42%9.55M
54.19%8.88M
135.50%28.38M
32.51%8.11M
14.25%7.56M
6.95M
Operating expense
42.58%26.8M
52.13%85.02M
76.03%24.67M
56.56%20.84M
55.62%20.71M
23.26%18.79M
111.09%55.89M
-3.95%14.02M
5.55%13.31M
13.31M
Selling and administrative expenses
45.62%21.6M
45.05%65.63M
54.04%17.97M
59.92%16.66M
49.66%16.17M
20.00%14.84M
132.40%45.24M
10.02%11.66M
14.82%10.42M
--10.8M
-Selling and marketing expense
93.27%12.64M
70.18%37.29M
61.08%10.22M
94.64%10.53M
87.60%10M
35.46%6.54M
158.65%21.91M
28.02%6.34M
48.29%5.41M
--5.33M
-General and administrative expense
8.05%8.96M
21.45%28.33M
45.65%7.75M
22.38%6.12M
12.69%6.17M
10.10%8.3M
112.17%23.33M
-5.77%5.32M
-7.71%5M
--5.47M
Research and development costs
13.26%5.19M
50.26%20.82M
100.21%6.77M
15.66%4.39M
65.94%5.08M
26.69%4.59M
82.67%13.86M
-19.51%3.38M
-7.54%3.8M
--3.06M
Other operating expenses
----
55.58%-1.43M
94.25%-59K
76.55%-212K
3.81%-530K
14.58%-627K
-454.31%-3.22M
-398.06%-1.03M
-58.60%-904K
---551K
Operating profit
-73.61%-17.21M
-55.08%-42.66M
-107.74%-12.27M
-61.90%-9.31M
-75.50%-11.17M
-4.47%-9.91M
-90.70%-27.51M
30.28%-5.91M
4.06%-5.75M
-6.36M
Net non-operating interest income expense
-33,800.00%-1.36M
-7,043.75%-1.14M
-18,600.00%-1.12M
-66.67%-10K
-75.00%-7K
-4K
5.88%-16K
25.00%-6K
-100.00%-6K
-4K
Non-operating interest expense
33,800.00%1.36M
7,043.75%1.14M
18,600.00%1.12M
66.67%10K
75.00%7K
--4K
-5.88%16K
-25.00%6K
100.00%6K
--4K
Other net income (expense)
-109.10%-66K
851.01%8.48M
984.10%6.34M
261.76%615K
634.86%801K
2,489.29%725K
2,247.37%892K
2,559.09%585K
2,328.57%170K
109K
Other non- operating income (expenses)
-109.10%-66K
851.01%8.48M
984.10%6.34M
261.76%615K
634.86%801K
2,489.29%725K
2,247.37%892K
2,559.09%585K
2,328.57%170K
--109K
Income before tax
-102.70%-18.63M
-32.62%-35.32M
-32.35%-7.05M
-55.82%-8.7M
-65.75%-10.37M
2.84%-9.19M
-84.90%-26.63M
37.01%-5.33M
6.73%-5.58M
-6.26M
Income tax
0.00%30K
83.33%66K
-50.00%12K
175.00%11K
225.00%13K
650.00%30K
44.00%36K
26.32%24K
-60.00%4K
4K
Net income
-102.36%-18.66M
-32.69%-35.38M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-84.83%-26.67M
36.87%-5.35M
6.82%-5.59M
-6.26M
Net income continuous Operations
-102.36%-18.66M
-32.69%-35.38M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-84.83%-26.67M
36.87%-5.35M
6.82%-5.59M
---6.26M
Minority interest income
Net income attributable to the parent company
-102.36%-18.66M
-32.69%-35.38M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-84.83%-26.67M
36.87%-5.35M
6.82%-5.59M
-6.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-102.36%-18.66M
-32.69%-35.38M
-31.98%-7.07M
-55.91%-8.71M
-65.85%-10.38M
2.57%-9.22M
-84.83%-26.67M
36.87%-5.35M
6.82%-5.59M
-6.26M
Basic earnings per share
-97.30%-0.73
-30.84%-1.4
-27.27%-0.28
-54.55%-0.34
-64.00%-0.41
2.63%-0.37
-84.48%-1.07
35.29%-0.22
15.38%-0.22
-0.25
Diluted earnings per share
-97.30%-0.73
-30.84%-1.4
-27.27%-0.28
-54.55%-0.34
-64.00%-0.41
2.63%-0.37
-84.48%-1.07
35.29%-0.22
15.38%-0.22
-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 5.25%11.1M45.68%50.14M50.13%14.2M50.08%13.65M41.01%11.75M39.94%10.55M146.64%34.42M36.32%9.46M3.73%9.09M8.34M
Operating revenue 5.25%11.1M45.68%50.14M50.13%14.2M50.08%13.65M41.01%11.75M39.94%10.55M146.64%34.42M36.32%9.46M3.73%9.09M--8.34M
Cost of revenue -9.24%1.51M28.79%7.78M33.33%1.8M38.10%2.11M59.02%2.2M-6.24%1.67M217.11%6.04M64.87%1.35M-28.70%1.53M1.39M
Gross profit 7.97%9.59M49.27%42.36M52.92%12.4M52.50%11.53M37.42%9.55M54.19%8.88M135.50%28.38M32.51%8.11M14.25%7.56M6.95M
Operating expense 42.58%26.8M52.13%85.02M76.03%24.67M56.56%20.84M55.62%20.71M23.26%18.79M111.09%55.89M-3.95%14.02M5.55%13.31M13.31M
Selling and administrative expenses 45.62%21.6M45.05%65.63M54.04%17.97M59.92%16.66M49.66%16.17M20.00%14.84M132.40%45.24M10.02%11.66M14.82%10.42M--10.8M
-Selling and marketing expense 93.27%12.64M70.18%37.29M61.08%10.22M94.64%10.53M87.60%10M35.46%6.54M158.65%21.91M28.02%6.34M48.29%5.41M--5.33M
-General and administrative expense 8.05%8.96M21.45%28.33M45.65%7.75M22.38%6.12M12.69%6.17M10.10%8.3M112.17%23.33M-5.77%5.32M-7.71%5M--5.47M
Research and development costs 13.26%5.19M50.26%20.82M100.21%6.77M15.66%4.39M65.94%5.08M26.69%4.59M82.67%13.86M-19.51%3.38M-7.54%3.8M--3.06M
Other operating expenses ----55.58%-1.43M94.25%-59K76.55%-212K3.81%-530K14.58%-627K-454.31%-3.22M-398.06%-1.03M-58.60%-904K---551K
Operating profit -73.61%-17.21M-55.08%-42.66M-107.74%-12.27M-61.90%-9.31M-75.50%-11.17M-4.47%-9.91M-90.70%-27.51M30.28%-5.91M4.06%-5.75M-6.36M
Net non-operating interest income expense -33,800.00%-1.36M-7,043.75%-1.14M-18,600.00%-1.12M-66.67%-10K-75.00%-7K-4K5.88%-16K25.00%-6K-100.00%-6K-4K
Non-operating interest expense 33,800.00%1.36M7,043.75%1.14M18,600.00%1.12M66.67%10K75.00%7K--4K-5.88%16K-25.00%6K100.00%6K--4K
Other net income (expense) -109.10%-66K851.01%8.48M984.10%6.34M261.76%615K634.86%801K2,489.29%725K2,247.37%892K2,559.09%585K2,328.57%170K109K
Other non- operating income (expenses) -109.10%-66K851.01%8.48M984.10%6.34M261.76%615K634.86%801K2,489.29%725K2,247.37%892K2,559.09%585K2,328.57%170K--109K
Income before tax -102.70%-18.63M-32.62%-35.32M-32.35%-7.05M-55.82%-8.7M-65.75%-10.37M2.84%-9.19M-84.90%-26.63M37.01%-5.33M6.73%-5.58M-6.26M
Income tax 0.00%30K83.33%66K-50.00%12K175.00%11K225.00%13K650.00%30K44.00%36K26.32%24K-60.00%4K4K
Net income -102.36%-18.66M-32.69%-35.38M-31.98%-7.07M-55.91%-8.71M-65.85%-10.38M2.57%-9.22M-84.83%-26.67M36.87%-5.35M6.82%-5.59M-6.26M
Net income continuous Operations -102.36%-18.66M-32.69%-35.38M-31.98%-7.07M-55.91%-8.71M-65.85%-10.38M2.57%-9.22M-84.83%-26.67M36.87%-5.35M6.82%-5.59M---6.26M
Minority interest income
Net income attributable to the parent company -102.36%-18.66M-32.69%-35.38M-31.98%-7.07M-55.91%-8.71M-65.85%-10.38M2.57%-9.22M-84.83%-26.67M36.87%-5.35M6.82%-5.59M-6.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -102.36%-18.66M-32.69%-35.38M-31.98%-7.07M-55.91%-8.71M-65.85%-10.38M2.57%-9.22M-84.83%-26.67M36.87%-5.35M6.82%-5.59M-6.26M
Basic earnings per share -97.30%-0.73-30.84%-1.4-27.27%-0.28-54.55%-0.34-64.00%-0.412.63%-0.37-84.48%-1.0735.29%-0.2215.38%-0.22-0.25
Diluted earnings per share -97.30%-0.73-30.84%-1.4-27.27%-0.28-54.55%-0.34-64.00%-0.412.63%-0.37-84.48%-1.0735.29%-0.2215.38%-0.22-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg